+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Radium-223"

Nuclear Medicine Radioisotopes Market Global Report 2026 - Product Thumbnail Image

Nuclear Medicine Radioisotopes Market Global Report 2026

  • Report
  • December 2026
  • 250 Pages
  • Global
From
Alpha Emitter Market Report 2026 - Product Thumbnail Image

Alpha Emitter Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Radiopharmaceutical Theranostics Market Report 2026 - Product Thumbnail Image

Radiopharmaceutical Theranostics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Radiotheranostics Market Report 2026 - Product Thumbnail Image

Radiotheranostics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Therapeutic Radiopharmaceuticals Market - Global Forecast 2026-2032 - Product Thumbnail Image

Therapeutic Radiopharmaceuticals Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 183 Pages
  • Global
From
Targeted Radiotherapy Drug Market - Global Forecast 2026-2032 - Product Thumbnail Image

Targeted Radiotherapy Drug Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 188 Pages
  • Global
From
Radiopharmaceutical Therapy Market - Global Forecast 2026-2032 - Product Thumbnail Image

Radiopharmaceutical Therapy Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 191 Pages
  • Global
From
From
Radiopharmaceuticals Market - Global Forecast 2026-2032 - Product Thumbnail Image

Radiopharmaceuticals Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 199 Pages
  • Global
From
Alpha Emitters Market - Global Forecast 2026-2032 - Product Thumbnail Image

Alpha Emitters Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 190 Pages
  • Global
From
Radioactive Medical Isotopes Market - Global Forecast 2026-2032 - Product Thumbnail Image

Radioactive Medical Isotopes Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 180 Pages
  • Global
From
Systemic Radiotherapy - Global Strategic Business Report - Product Thumbnail Image

Systemic Radiotherapy - Global Strategic Business Report

  • Report
  • November 2026
  • 180 Pages
  • Global
From
Alpha Emitters - Global Strategic Business Report 2026 - Product Thumbnail Image

Alpha Emitters - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 124 Pages
  • Global
From
From
From
From
From
Loading Indicator

Radium-223 is a radioactive isotope of radium used in nuclear medicine and radiopharmacology. It is used to treat prostate cancer that has spread to the bones, as it emits alpha particles that can kill cancer cells while sparing healthy tissue. Radium-223 is administered intravenously and is typically used in combination with other treatments such as hormone therapy. Radium-223 is produced in nuclear reactors and is available in a variety of formulations. It is typically supplied as a solution in a vial, which is then further diluted for administration. The shelf life of the product is typically short, and it must be stored and handled in accordance with safety regulations. The market for Radium-223 is relatively small, but it is growing as the demand for treatments for prostate cancer increases. Companies in the market include Algeta, Bayer, and Advanced Accelerator Applications. Show Less Read more